USX:PHAT - Phathom Pharmaceuticals Inc

Phathom Pharmaceuticals Inc
Sector: Health Care, Industry: Biotechnology

Add to Watchlist

•  Default
• New Watchlist

   

Yahoo Finance (Live Price)

• Summary
• Financials
• Dividend
• Prices
• Posts
• User
• Alerts
• Charts

Balance Sheet Cash Flow Income Statement Key Ratios Personalized

Show %	2018 Q4	2019 Q2	2019 Q3	2019 Q4	2020 Q1	2020 Q2	2020 Q3	2020 Q4	2021 Q1	2021 Q2	2021 Q3	2021 Q4	2022 Q1	2022 Q2	2022 Q3	2022 Q4	2023 Q1	2023 Q2	2023 Q3	2023 Q4	2024 Q1	Graph
Total Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	214.58M -12.9%	228.38M 6.4%	189.43M -17.1%	149.05M -21.3%	213.5M 43.2%	201.93M -5.4%	164.81M -18.4%	144.01M -12.6%	265.04M 84.0%	236.99M -10.6%	413.84M 74.6%	356.5M -13.9%
Current Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	211.34M -13.0%	225.31M 6.6%	186.53M -17.2%	145.74M -21.9%	209.26M 43.6%	197.81M -5.5%	160.51M -18.9%	139.84M -12.9%	257.72M 84.3%	226.73M -12.0%	397.43M 75.3%	340.31M -14.4%
Cash+Equi+Others	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	209.67M -11.9%	224.62M 7.1%	183.26M -18.4%	138.09M -24.6%	207.39M 50.2%	196.84M -5.1%	155.38M -21.1%	129.57M -16.6%	248.85M 92.1%	213.68M -14.1%	381.39M 78.5%	322.23M -15.5%
NonCurrent Assets	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	3.24M -8.8%	3.06M -5.5%	2.9M -5.2%	3.31M 13.9%	4.25M 28.3%	4.12M -3.0%	4.3M 4.4%	4.17M -3.0%	7.32M 75.7%	10.27M 40.2%	16.41M 59.8%	16.18M -1.4%
Total Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	82.45M 0.5%	124.9M 51.5%	117.28M -6.1%	111.01M -5.3%	220.5M 98.6%	228.35M 3.6%	239.62M 4.9%	234.21M -2.3%	247.44M 5.7%	254.76M 3.0%	486.6M 91.0%	505M 3.8%
Current Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	39.61M -3.0%	27.81M -29.8%	18.92M -32.0%	11.39M -39.8%	21.07M 85.0%	22.88M 8.6%	26.24M 14.7%	14.44M -45.0%	21.55M 49.2%	23.98M 11.3%	38.78M 61.7%	43.46M 12.1%
NonCurrent Liabilities	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	42.84M 4.0%	97.08M 126.6%	98.35M 1.3%	99.62M 1.3%	199.43M 100.2%	205.47M 3.0%	213.39M 3.9%	219.76M 3.0%	225.89M 2.8%	230.79M 2.2%	447.82M 94.0%	461.54M 3.1%
Total Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	132.13M -19.6%	103.48M -21.7%	72.16M -30.3%	38.03M -47.3%	-7M -	-26.42M -	-74.81M -	-90.19M -	17.6M -	-17.77M -	-72.76M -	-148.5M -
Stockholders Equity	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	132.13M -19.6%	103.48M -21.7%	72.16M -30.3%	38.03M -47.3%	-7M -	-26.42M -	-74.81M -	-90.19M -	17.6M -	-17.77M -	-72.76M -	-148.5M -
Minority Interest	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	[friend]	-	-	-	-	-	-	-	-	-	-	-	-